Skip to main content
. 2021 Sep 23;8:734838. doi: 10.3389/fmed.2021.734838

Figure 3.

Figure 3

Changes in the serum levels of IL-6, soluble IL-6 receptor, and soluble gp130 before and after tocilizumab administration. The serum levels of IL-6, soluble IL-6 receptor (sIL-6R), and soluble gp130 (sgp130) in 10 patients with COVID-19 before and after tocilizumab administration were measured using a multiplex cytokine array system. The red line represents the data of patients requiring mechanical ventilation.